Home › COPD › North Carolina › Winston-Salem
COPD clinical trials in Winston-Salem, NC
11 studies for COPD are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Recruiting
- Wake Forest Baptist Medical Center, Winston-Salem
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2/3
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
RecruitingPhase 4
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400048, Winston-Salem
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
RecruitingPhase 3
- GSK Investigational Site, Winston-Salem
- GSK Investigational Site, Winston-Salem
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, Winston-Salem
Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
RecruitingPhase 4
- Southeastern Research Center, Winston-Salem
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RecruitingPhase 3
- Research Site, Winston-Salem
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RecruitingPhase 3
- GSK Investigational Site, Winston-Salem
SPIROMICS Study of Early COPD Progression (SOURCE)
RecruitingObservational studyHealthy volunteers welcome
- Wake Forest, Winston-Salem
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA26 studies
- Miami, FL20 studies
- Houston, TX18 studies
- Birmingham, AL17 studies
- Baltimore, MD16 studies
- Boston, MA15 studies
- Orlando, FL15 studies
- Chicago, IL15 studies
- Dallas, TX13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Hialeah, FL10 studies
Other studies in Winston-Salem
- Acute Myeloid Leukemia20 studies
- Cancer (all types)19 studies
- Multiple Myeloma16 studies
- Breast Cancer15 studies
- Cardiovascular Disease13 studies
- Non-Small Cell Lung Cancer11 studies
- Ovarian Cancer10 studies
- Myeloproliferative Neoplasms9 studies
- Myelofibrosis9 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Chronic Lymphocytic Leukemia9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.